G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects

Journal of General Physiology

Volumn 129, Issue 4, 2007, Pages 285-298

  Bompadre, Silvia G ^a,b   Sohma, Yoshiro ^b,c   Li, Min ^a,b   Hwang, Tzyh Chang ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CHLORIDE CHANNEL; MAGNESIUM; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE MUTATION; GENE SEQUENCE; HYDROLYSIS; NONHUMAN; NUCLEOTIDE BINDING SITE; PHENOTYPE;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CRICETULUS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE EXPRESSION; HUMANS; ION CHANNEL GATING; KINETICS; MEMBRANE POTENTIALS; MUTAGENESIS, SITE-DIRECTED; PATCH-CLAMP TECHNIQUES; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 33947725805     PISSN: 00221295     EISSN: 00221295     Source Type: Journal    
DOI: 10.1085/jgp.200609667     Document Type: Article

References (58)

1. Ai, T., S.G. Bompadre, X. Wang, S. Hu, M. Li, and T.-C. Hwang. 2004. Capsaicin potentiates wild-type and mutant CFTR chloride channel currents. Mol. Pharmacol. 65:1415-1426.
2. Aleksandrov, L., A. Mengos, X.-B. Chang, A. Aleksandrov, and J.R. Riordan. 2001. Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 276:12918-12923.
3. Anderson, M.P., and M.J. Welsh. 1992. Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science. 257:1701-1704.
4. Beaudet, A.L., G.L. Feldman, K. Kobayashi, W.K. Lemma, S.D. Fernbach, M.R. Knowles, R.C. Boucher, and W.E. O'Brien. 1991. Mutation analysis for cystic fibrosis in a North American population. In The Identification of the CF (cystic fibrosis) Gene-recent Progress and New Research Strategies. L-C. Tsui, G. Romeo, R. Greger, and S. Gorini, editors. Plenum Press, New York. 53-54.
5. Becq, F., T.J. Jensen, X.B. Chang, A. Savoia, J.M. Rommens, L.C. Tsui, M. Buchwald, J.R. Riordan, and J.W. Hanrahan. 1994. Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc. Natl. Acad. Sci. USA. 91:9160-9164.
6. 2+-independent activation of cystic fibrosis transmembrane conductance regulator channels by phenylimidazothiazole drugs. J. Biol. Chem. 271:16171-16179.
7. Berger, A.L., M. Ikuma, and M.J. Welsh. 2005. Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain. Proc. Natl. Acad. Sci. USA. 102:455-460.
8. Bompadre, S.G., T. Ai, J.H. Cho, X. Wang, Y. Sohma, M. Li, and T.-C. Hwang. 2005a.CFTR gating I: characterization of the ATPdependent gating of a phosphorylation-independent CFTR construct (ΔR-CFTR). J. Gen. Physiol. 125:361-375.
9. Bompadre, S.G., J.H. Cho, X. Wang, X. Zou, Y. Sohma, M. Li, and T.-C. Hwang. 2005b. CFTR gating II: effects of nucleotide binding on the stability of open states. J. Gen. Physiol. 125:377-394.
10. Brancolini, V., L. Cremonesi, E. Belloni, E. Pappalardo, R. Bordoni, M. Seia, S. Russo, R. Padoan, A. Giunta, and M. Ferrari. 1995. Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations. Hum. Genet. 96:312-318.
11. ? channel. J. Biol. Chem. 281:1970-1977.
12. Chang, X.-B., J.A. Tabcharani, Y.-X. Hou, T.J. Jensen, N. Kartner, N.W. Alon, J.W. Hanrahan, and J.R. Riordan. 1993. Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J. Biol. Chem. 268:11304-11311.
13. Colquhoun, D., and A.G. Hawkes. 1995. A Q-matrix cookbook: how to write only one program to calculate the single-channel and macroscopic prediction for any kinetic mechanism. In Single-Channel Recording. B. Sakmann, and E. Neher, editors. Plenum Press, New York. 589-633.
14. Csanády, L. 2000. Rapid kinetic analysis of multichannel records by a simultaneous fit to all dwell-time histograms. Biophys. J. 78:785-799.
15. Cutting, G.R., L.M. Kasch, B.J. Rosenstein, J. Zielenski, L.C. Tsui, S.E. Antonarakis, and H.H. Kazazian Jr. 1990. A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature. 346:366-369.
16. Davis, P.B. 2001. Cystic Fibrosis. Pediatr. Rev. 22:257-264.
17. 2+-dependent steps rate limit opening and closing of a single CFTR Cl channel. J. Gen. Physiol. 119:545-559.
18. Drumm, M.L., D.J. Wilkinson, L.S. Smit, R.T. Worrell, T.V. Strong, R.A. Frizzell, D.C. Dawson, and F.S. Collins. 1991. Choride conductance expressed by ΔF508 and other mutant CFTRs in Xenopus oocytes. Science. 254:1797-1799.
19. Gadsby, D.C., P. Vergani, and L. Csanady. 2006. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature. 440:477-483.
20. Galietta, L.J., M.F. Springsteel, M. Eda, E.J. Niedzinski, K. By, M.J. Haddadin, M.J. Kurth, M.H. Nantz, and A.S. Verkman. 2001. Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds. J. Biol. Chem. 276:19723-19728.
21. Gregory, R.J., D.P. Rich, S.H. Cheng, D.W. Souza, S. Paul, P. Manavalan, M.P. Anderson, M.J. Welsh, and A.E. Smith. 1991. Maturation and function of the cystic fibrosis transmembrane regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol. Cell. Biol. 11:3886-3893.
22. Gunderson, K.L., and R.R. Kopito. 1994. Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating. J. Biol. Chem. 269:19349-19353.
23. ? channel. Trends Pharmacol. Sci. 20:448-453.
24. Hwang, T.-C., G. Nagel, A.C. Nairn, and D.C. Gadsby. 1994. Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis. Proc. Natl. Acad. Sci. USA. 91:4698-4702.
25. Hwang, T.-C., R.E. Koeppe, and O.S. Andersen. 2003. Genistein can modulate channel function by a phosphorylation-independent mechanism: importance of hydrophobic mismatch and bilayer mechanics. Biochemistry. 42:13646-13658.
26. Illek, B., L. Zhang, N.C. Lewis, R.B. Moss, J.Y. Dong, and H. Fischer. 1999. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am. J. Physiol. 277:C833-C839.
27. Kerem, B.-S., J. Zielenski, D. Markiewicz, D. Bozon, E. Gazit, J. Yahav, D. Kennedy, J.R. Riordan, F.S. Collins, J.M. Rommens, and L.-C. Tsui. 1990. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc. Natl. Acad. Sci. USA. 87:8447-8451.
28. Lewis, H.A., S.G. Buchanan, S.K. Burley, K. Conners, M. Dickey, M. Dorwart, R. Fowler, X. Gao, W.B. Gruggino, W.A. Hendrickson, et al. 2004. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 23:282-293.
29. Li, C., M. Ramjeesingh, W. Wang, E. Garami, M. Hewryk, D. Lee, J.M. Rommens, K. Galley, and C.E. Bear. 1996. ATPase activity of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 271:28463-28468.
30. Locher, K.P., A.T. Lee, and D.C. Rees. 2002. The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science. 296:1091-1098.
31. Logan, J., D. Hiestand, P. Daram, Z. Huang, D.D. Muccio, J. Hartman, B. Haley, W.J. Cook, and E.J. Sorscher. 1994. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J. Clin. Invest. 94:228-236.
32. Lu, G., J.M. Westbrooks, A.L. Davidson, and J. Chen. 2005. ATP hydrolysis is required to reset the ATP-binding cassette dimer into the resting-state conformation. Proc. Natl. Acad. Sci. USA. 102:17969-17974.
33. Mathews, C.J., J.A. Tabcharani, and J.W. Hanrahan. 1998. The CFTR chloride channel nucleotide interactions and temperature-dependent gating. J. Membr. Biol. 163:55-66.
34. Moran, O., L.J. Galietta, and O. Zegarra-Moran. 2005. Binding site of activators of the cystic fibrosis transmembrane conductance regu lator in the nucleotide binding domains. Cell. Mol. Life Sci. 62:446-460.
35. Pedemonte, N., N.D. Sonawane, A. Taddei, J. Hu, O. Zegarra-Moran, Y.F. Suen, L.I. Robins, C.W. Dicus, D. Willenbring, M.H. Nantz, et al. 2005. Phenylglycine and sulfonamide correctors of defective ΔF508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating. Mol. Pharmacol. 67:1797-1807.
36. Powe, A., L. Al-Nakkash, M. Li, and T.-C. Hwang. 2002. Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide binding domains. J. Physiol. 539:333-346.
37. Quinton, P.M. 1990. Cystic fibrosis: a disease in electrolyte transport. FASEB J. 4:2709-2717.
38. Ren, X.Q., T. Furukawa, M. Haraguchi, T. Sumizawa, S. Aoki, M. Kobayashi, and S. Akiyama. 2004. Function of the ABC signature sequences in human multidrug resistance protein 1. Mol. Pharmacol. 65:1536-1542.
39. Riordan, J.R., J.M. Rommens, B.-S. Kerem, N. Alon, R. Rozmahel, Z. Grzelzak, J. Zielenski, S. Lok, N. Plavsic, J.-L. Chou, et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1066-1072.
40. Salvatore, F., O. Scudiero, and G. Castaldo. 2002. Genotype-phenotype correlations in cystic fibrosis: the role of modifier genes. Am. J. Med. Genet. 111:88-95.
41. ? channels with altered pore properties. Nature. 362:160-164.
42. Smith, P.C., N. Karpowich, L. Millen, J.E. Moody, J. Rosen, P.J. Thomas, and J.F. Hunt. 2002. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol. Cell. 10:139-149.
43. Tsui, L.C., and P. Durie. 1997. Genotype and phenotype in cystic fibrosis. Hosp. Pract. 32:115-118, 123-129, 134.
44. ? channels. J. Gen. Physiol. 121(1):17-36.
45. Vergani, P., S.W. Lockless, A.C. Nairn, and D.C. Gadsby. 2005. CFTR opening by ATP-driven tight dimerization of its nucleotide binding domains. Nature. 433:876-880.
46. Wang, F., S. Zeltwanger, I. Yang, A. Nairn, and T.-C. Hwang. 1998. Action of genistein on CFTR gating: evidence of two binding sites with opposite effects. J. Gen. Physiol. 111:477-490.
47. Wang, F., S. Zeltwanger, S. Hu, and T.-C. Hwang. 2000. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels. J. Physiol. 524:637-648.
48. Wang, W., K. Bernard, G. Li, and K.L. Kirk. 2007. Curcumin opens CFTR channels by a novel mechanism that requires neither ATP binding NOR dimerization of the nucleotide binding domains. J. Biol. Chem. 282:4533-4544.
49. Weinreich, F., P.G. Wood, J.R. Riordan, and G. Nagel. 1997. Direct action of genistein on CFTR. Pflugers Arch. 434:484-491.
50. Welsh, M.J., and A.E. Smith. 1993. Molecular mechanisms of the CFTR chloride channel dysfunction in cystic fibrosis. Cell. 73:1251-1254.
51. Wilkinson, D.J., M.K. Mansoura, P.Y. Watson, L.S. Smit, F.S. Collins, and D.C. Dawson. 1996. CFTR: the nucleotide binding folds regulate the accessibility and stability of the activated state. J. Gen. Physiol. 107:103-119.
52. ? channels: a kinetic analysis of channel regulation. Biophys. J. 66:1398-1403.
53. Zeltwanger, S., F. Wang, G.T. Wang, K.D. Gillis, and T.-C. Hwang. 1999. Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme. J. Gen. Physiol. 113:541-554.
54. Zhou, Z., S. Hu, and T.-C. Hwang. 2001. Voltage-dependent flickery block of an open cystic fibrosis transmembrane conductance regulator (CFTR) channel pore. J. Physiol. 532:435-448.
55. Zhou, Z., S. Hu, and T.-C. Hwang. 2002. Probing an open CFTR pore with organic anion blockers. J. Physiol. 120:647-662.
56. Zhou, Z., X. Wang, M. Li, Y. Sohma, X. Zou, and T.-C. Hwang. 2005. High affinity ATP/ADP analogs as new tools for studying CFTR gating. J. Physiol. 569:447-457.
57. Zhou, Z., X. Wang, H.-Y. Liu, X. Zou, M. Li, and T.-C. Hwang. 2006. The two ATP binding sites of the cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics. J. Gen. Physiol. 128:413-422.
58. Zhou, Z., and T.-C. Hwang. 2007. Gating of the cystic fibrosis transmembrane regulator (CFTR) chloride channels. In Advances in Molecular Biology, 38. E.E. Bittar, editor. Elsevier, New York. 145-180.